Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by allibabbaon Dec 16, 2020 2:41pm
114 Views
Post# 32120516

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TGA approves CBD down scheduling.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TGA approves CBD down scheduling.I did say to friends more than a year and a half ago that mergers were going to happen and companies too stubborn to bite their pride and make a deal were going to get left for the vultures.  I am very interested in the aphria/tilray deal.  I think you will see a similar deal with canopy growth in the near future.  Cronos also has to make a deal VERY soon or the are toast.  I am hoping that Pat getting thrown out is a step in the right direction.  In my opinion LABS cannot survive without a large partner.  The warning bells are sounding now and hopefully it's not too late.
<< Previous
Bullboard Posts
Next >>